It has been a two-year collaboration in the field of crop protection that has finally borne fruit. Dow AgroSciences India Private Ltd, a wholly owned subsidiary of The Dow Chemical Company, which had teamed up with the Hyderabad-based GVK Biosciences Private Ltd to generate novel molecules for synthesis in the field of fungicide and insecticide discovery research, has hit an important milestone. The two companies, which have used their depth of expertise in medicinal chemistry and cheminformatics at India's GVK in combination with Dow AgroSciences agrochemical capabilities, have identified a new lead molecule for advancement. The newly discovered compound is set to address a key product goal of the Indianapolis-based agricultural company Dow AgroSciences' growing agricultural chemicals business. GVK Biosciences is touted as Asia's leading contract research organisation. A deal between the two firms was signed in 2008, and allowed for both companies to further research molecules for testing as fungicides and insecticides.
Daniel R Kittle, vice president of research and development at Dow AgroSciences, said the company would "continue to invest in the strong agricultural chemicals business. We are building partnerships with some of the world's best research teams to discover creative new solutions in crop protection." Manni Kantipudi, chief executive officer, GVK Biosciences, said the collaboration had validated GVK Biosciences' expertise in agro-chemical research. The Indian firm provides contract research services to a rapidly growing base of global pharmaceutical and biotechnology companies to help them address their drug development challenges. The firm has also tied up with Bayer CropScience Ltd in November 2009, to conduct research in the area of early discovery chemistry. The objective was to speed up the search for promising active ingredients for innovative crop protection products. "Under the agreement, Bayer CropScience has integrated GVK Bio's capacities in the early part of its discovery chemistry process," said an official, who did not want to be identified.